Nonclassical MHC class II molecules

Annual Review of Immunology

Volumn 18, Issue , 2000, Pages 113-142

  Alfonso, Christopher ^a   Karlsson, Lars ^a  

^a JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Antigen processing; HLA DM; HLA DO

Indexed keywords

HLA ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MEMBRANE PROTEIN;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; HLA SYSTEM; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

ANIMALS; BIOLOGICAL TRANSPORT; CHROMOSOME MAPPING; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-D ANTIGENS; HUMANS; MICE; SUBCELLULAR FRACTIONS; TISSUE DISTRIBUTION;

EID: 0034082410     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.18.1.113     Document Type: Review

References (179)

1. Watts C. 1997. Capture and processing of exogenous antigens for presentation on MHC molecules. Annu. Rev. Immunol. 15:821-50
2. Wolf PR, Ploegh HL. 1995. How MHC class II molecules acquire peptide cargo: biosynthesis and trafficking through the endocytic pathway. Annu. Rev. Cell Dev. Biol. 11:267-306
3. Cresswell P. 1996. Invariant chain structure and MHC class II function. Cell 84:505-7
4. Trowsdale J, Kelly A. 1985. The human HLA class II alpha chain gene DZ alpha is distinct from genes in the DP, DQ and DR subregions. EMBO J. 4:2231-37
5. Inoko H, Ando A, Kimura M, Tsuji K. 1985. Isolation and characterization of the cDNA clone and genomic clones of a new HLA class II antigen heavy chain, DO alpha. J. Immunol. 135:2156-59
6. Tonnelle C, DeMars R, Long EO. 1985. DO beta: a new beta chain gene in HLA-D with a distinct regulation of expression. EMBO J. 4:2839-47
7. Servenius B, Rask L, Peterson PA. 1987. Class II genes of the human major histocompatibility complex. The DO beta gene is a divergent member of the class II beta gene family. J. Biol. Chem. 262:8759-66
8. Larhammar D, Hammerling U, Rask L, Peterson PA. 1985. Sequence of gene and cDNA encoding murine major histocompatibility complex class II gene A beta 2. J. Biol. Chem. 260:14111-19
9. Steinmetz M, Minard K, Horvath S, McNicholas J, Srelinger J, Wake C, Long E, Mach B, Hood L. 1982. A molecular map of the immune response region from the major histocompatibility complex of the mouse. Nature 300:35-42
10. Braunstein NS, Germain RN. 1986. The mouse E beta 2 gene: a class II MHC beta gene with limited intraspecies polymorphism and an unusual pattern of transcription. EMBO J. 5:2469-76
11. Trowsdale J. 1995. "Both man & bird & beast": comparative organization of MHC genes. Immunogenetics 41:1-17
12. Beck S, Trowsdale J. 1999. Sequence organisation of the class II region of the human MHC. Immunol. Rev. 167:201-10
13. Kelly AP, Monaco JJ, Cho SG, Trowsdale J. 1991. A new human HLA class II-related locus, DM. Nature 353: 571-73
14. Cho SG, Attaya M, Monaco JJ. 1991. New class II-like genes in the murine MHC. Nature 353:573-76
15. Cho SG, Attaya M, Brown MG, Monaco JJ. 1991. A cluster of transcribed sequences between the Pb and Ob genes of the murine major histocompatibility complex. Proc. Natl. Acad. Sci. USA 88:5197-5201
16. Pamer E, Cresswell P. 1998. Mechanisms of MHC class I-restricted antigen processing. Annu. Rev. Immunol. 16:323-58
17. Radley E, Alderton RP, Kelly A, Trowsdale J, Beck S. 1994. Genomic organization of HLA-DMA and HLA-DMB. Comparison of the gene organization of all six class II families in the human major histocompatibility complex. J. Biol. Chem. 269:18834-38
18. Cho SG, Attaya M, Brown MG, Monaco JJ. 1991. A cluster of transcribed sequences between the Pb and Ob genes of the murine major histocompatibility complex. Proc. Natl. Acad. Sci. USA 88:5197-5201
19. Peleraux A, Karlsson L, Chambers J, Peterson PA. 1996. Genomic organization of a mouse MHC class II region including the H2-M and Lmp2 loci. Immunogenetics 43:204-14
20. Hermel E, Monaco JJ. 1995. RT1.DMa and RT1.DMb: the rat homologues of H2-DMa and H2-DMb. Immunogenetics 42:446-47
21. Karlsson L, Peleraux A, Lindstedt R, Liljedahl M, Peterson PA. 1994. Reconstitution of an operational MHC class II compartment in nonantigen-presenting cells. Science 266:1569-73
22. Hermel E, Yuan J, Monaco JJ. 1995. Characterization of polymorphism within the H2-M MHC class II loci. Immunogenetics 42:136-42
23. Walter W, Loos M, Maeurer MJ. 1996. H2-M polymorphism in mice susceptible to collagen-induced arthritis involves the peptide binding groove. Immunogenetics 44:19-26
24. Morris P, Shaman J, Attaya M, Amaya M, Goodman S, Bergman C, Monaco JJ, Mellins E. 1994. An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules. Nature 368:551-54
25. Stebbins CC, Peterson ME, Suh WM, Sant AJ. 1996. DM-mediated release of a naturally occurring invariant chain degradation intermediate from MHC class II molecules. J. Immunol. 157:4892-98
26. Carrington M, Yeager M, Mann D. 1993. Characterization of HLA-DMB polymorphism. Immunogenetics 38:446-49
27. Sanderson F, Powis SH, Kelly AP, Trowsdale J. 1994. Limited polymorphism in HLA-DM does not involve the peptide binding groove. Immunogenetics 39:56-58
28. Djilali-Saiah I, Benini V, Schmitz J, Timsit J, Assan R, Boitard C, Bach J-F, Caillat-Zucman S. 1996. Absence of primary association between DM gene polymorphism and insulin-dependent diabetes mellitus or celiac disease. Hum. Immunol. 49:22-27
29. Kim T-G, Carrington M, Choi H-B, Kim H-Y, Han H. 1996. Three HLA-DMB variants in Korean patients with autoimmune diseases. Hum. Immunol. 46:58-60
30. Kuwata S, Yanagisawa M, Nakagawa H, Saeki H, Etoh T, Miyamoto M, Juji T. 1996. HLA-DM gene polymorphisms in atopic dermatitis. J. Allergy Clin. Immunol. 98:5192-200
31. Ishihara M, Naruse T, Ohno S, Kawata H, Mizuki N, Yamagata N, Ishida T, Nose Y, Inoko H. 1996. Analysis of HLA-DM polymorphisms in sarcoidosis. Hum. Immunol. 49:144-46
32. Pinet V, Combe B, Avinens O, Caillat-Zucman S, Sany J, Clot J, Eliaou JF. 1997. Polymorphism of the HLA-DMA and DMB genes in rheumatoid arthritis. Arthritis Rheum. 40:854-58
33. Chang CH, Flavell RA. 1995. Class II transactivator regulates the expression of multiple genes involved in antigen presentation. J. Exp. Med. 181:765-67
34. Kern I, Steimle V, Siegrist CA, Mach B. 1995. The two novel MHC class II transactivators RFX5 and CIITA both control expression of HLA-DM genes. Int. Immunol. 7:1295-99
35. Chang CH, Guerder S, Hong SC, van Ewijk W, Flavell RA. 1996. Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression. Immunity 4:167-78
36. Clausen BE, Waldburger JM, Schwenk F, Barras E, Mach B, Rajewsky K, Forster I, Reith W. 1998. Residual MHC class II expression on mature dendritic cells and activated B cells in RFX5-deficient mice. Immunity 8:143-55
37. Fling SP, Rak J, Muczynski KA, Arp B, Pious D. 1997. Novel mutants define genes required for the expression of human histocompatibility leukocyte antigen DM: evidence for loci on human chromosome 6p. J. Exp. Med. 186:1469-80
38. Niimi M, Nakai Y, Aida Y. 1995. Nucleotide sequences and the molecular evolution of the DMA and DMB genes of the bovine major histocompatibility complex. Biochem. Biophys. Res. Commun. 217:522-28
39. Hermel E, Han M, Hague B, Kindt T, Monaco JJ. 1999. Isolation and mapping of the rabbit DM genes. Immunogenetics 49:295-302
40. Ponzoni M, Guarnaccia F, Corrias MV, Cornaglia-Ferraris P. 1993. Uncoordinate induction and differential regulation of HLA class-I and class-II expression by gamma-interferon in differentiating human neuroblastoma cells. Int. J. Cancer. 55:817-23
41. Denzin LK, Sant' Angelo DB, Hammond C, Surman MJ, Cresswell P. 1997. Negative regulation by HLA-DO of MHC class II-restricted antigen processing. Science 278:106-9
42. Voliva CF, Tsang S, Peterlin BM. 1993. Mapping cis-acting defects in promoters of transcriptionally silent DQA2, DQB2, and DOB genes. Proc. Natl. Acad. Sci. USA 90:3408-12
43. Karlsson L, Surh CD, Sprent J, Peterson PA. 1991. A novel class II MHC molecule with unusual tissue distribution. Nature 351:485-88
44. Larhammar D, Hammerling U, Denaro M, Lund T, Flavell RA, Rask L, Peterson PA. 1983. Structure of the murine immune response I-A beta locus: sequence of the I-A beta gene and an adjacent beta-chain second domain exon. Cell 34:179-88
45. Karlsson L, Peterson PA. 1992. The α chain gene of H-2O has an unexpected location in the major histocompatibility complex. J. Exp. Med. 176:477-83
46. Wake CT, Flavell RA. 1985. Multiple mechanisms regulate the expression of murine immune response genes. Cell 42:623-28
47. Surh CD, Gao EK, Kosaka H, Lo D, Ahn C, Murphy DB, Karlsson L, Peterson P, Sprent J. 1992. Two subsets of epithelial cells in the thymic medulla. J. Exp. Med. 176:495-505
48. Liljedahl M, Kuwana T, Fung-Leung WP, Jackson MR, Peterson PA, Karlsson L. 1996. HLA-DO is a lysosomal resident which requires association with HLA-DM for efficient intracellular transport. EMBO J. 15:4817-24
49. Douek DC, Altmann DM. 1997. HLA-DO is an intracellular class II molecule with distinctive thymic expression. Int. Immunol. 9:355-64
50. Vogt AB, Hammerling GJ, Kropshofer H. 1998. HLA-DM and HLA-DO: a chaperone and its modulator influencing the peptide repertoire seen by T cells. Immunologist 6:186-93
51. Liljedahl M, Winqvist O, Surh CD, Wong P, Ngo K, Teyton L, Peterson PA, Brunmark A, Rudensky AY, Fung-Leung WP, Karlsson L. 1998. Altered antigen presentation in mice lacking H2-O. Immunity 8:233-43
52. Jonsson AK, Rask L. 1989. Human class II DNA and DOB genes display low sequence variability. Immunogenetics 29:411-13
53. Naruse TK, Kawata H, Anzai T, Takashige N, Kagiya M, Nose Y, Nabeya N, Isshiki G, Tatsumi N, Inoko H. 1999. Limited polymorphism in the HLA-DOA gene. Tissue Antigens 53:359-65
54. Karlsson L, Peterson PA. 1992. The alpha chain gene of H-2O has an unexpected location in the major histocompatibility complex. J. Exp. Med. 176:477-83
55. Cresswell P. 1994. Assembly, transport, and function of MHC class II molecules. Annu. Rev. Immunol. 12:259-93
56. Busch R, Cloutier I, Sekaly RP, Hammerling GJ. 1996. Invariant chain protects class II histocompatibility antigens from binding intact polypeptides in the endoplasmic reticulum. EMBO J. 15: 418-28
57. Aichinger G, Karlsson L, Jackson MR, Vestberg M, Vaughan JH, Teyton L, Lechler RI, Peterson PA. 1997. Major histocompatibility complex class II-dependent unfolding, transport, and degradation of endogenous proteins. J. Biol. Chem. 272:29127-36
58. Romagnoli P, Germain RN. 1994. The CLIP region of invariant chain plays a critical role in regulating major histocompatibility complex class II folding, transport, and peptide occupancy. J. Exp. Med. 180:1107-13
59. Ghosh P, Amaya M, Mellins E, Wiley DC. 1995. The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3. Nature 378:457-62
60. Park SJ, Sadegh-Nasseri S, Wiley DC. 1995. Invariant chain made in Escherichia coli has an exposed N-terminal segment that blocks antigen binding to HLA-DR1 and a trimeric C-terminal segment that binds empty HLA-DR1. Proc. Natl. Acad. Sci. USA 92:11289-93
61. Jasanoff A, Song S, Dinner AR, Wagner G, Wiley DC. 1999. One of two unstructured domains of Ii becomes ordered in complexes with MHC class II molecules. Immunity 10:761-68
62. Sette A, Southwood S, Miller J, Appella E. 1995. Binding of major histocompatibility complex class II to the invariant chain-derived peptide, CLIP, is regulated by allelic polymorphism in class II. J. Exp. Med. 181:677-83
63. Siebenkotten IM, Carstens C, Koch N. 1998. Identification of a sequence that mediates promiscuous binding of invariant chain to MHC class II allotypes. J. Immunol. 160:3355-62
64. Wilson NA, Wolf P, Ploegh H, Ignatowicz L, Kappler J, Marrack P. 1998. Invariant chain can bind MHC class II at a site other than the peptide binding groove. J. Immunol. 161:4777-84
65. Thayer WP, Ignatowicz L, Weber DA, Jensen PE. 1999. Class II-associated invariant chain peptide-independent binding of invariant chain to class II MHC molecules. J. Immunol. 162:1502-9
66. Bakke O, Dobberstein B. 1990. MHC class II-associated invariant chain contains a sorting signal for endosomal compartments. Cell 63:707-16
67. Lotteau V, Teyton L, Peleraux A, Nilsson T, Karlsson L, Schmid SL, Quaranta V, Peterson PA. 1990. Intracellular transport of class II MHC molecules directed by invariant chain. Nature 348:600-5
68. Odorizzi CG, Trowbridge IS, Xue L, Hopkins CR, Davis CD, Collawn JF. 1994. Sorting signals in the MHC class II invariant chain cytoplasmic tail and transmembrane region determine trafficking to an endocytic processing compartment. J. Cell Biol. 126:317-30
69. Pond L, Kuhn LA, Teyton L, Schutze MP, Tainer JA, Jackson MR, Peterson PA. 1995. A role for acidic residues in dileucine motif-based targeting to the endocytic pathway. J. Biol. Chem. 270:19989-97
70. Peters PJ, Neefjes JJ, Oorschot V, Ploegh HL, Geuze HJ. 1991. Segregation of MHC class II molecules from MHC class I molecules in the Golgi complex for transport to lysosomal compartments. Nature 349:669-76
71. Benaroch P, Yilla M, Raposo G, Ito K, Miwa K, Geuze HJ, Ploegh HL. 1995. How MHC class II molecules reach the endocytic pathway. EMBO J. 14:37-49
72. Kleijmeer MJ, Morkowski S, Griffith JM, Rudensky AY, Geuze HJ. 1997. Major histocompatibility complex class II compartments in human and mouse B lymphoblasts represent conventional endocytic compartments. J. Cell Biol. 139:639-49
73. Castellino F, Germain RN. 1995. Extensive trafficking of MHC class II-invariant chain complexes in the endocytic pathway and appearance of peptide-loaded class II in multiple compartments. Immunity 2:73-88
74. Roche PA, Teletski CL, Stang E, Bakke O, Long EO. 1993. Cell surface HLA-DR-invariant chain complexes are targeted to endosomes by rapid internalization. Proc. Natl. Acad. Sci. USA 90:8581-85
75. Wang K, Peterson PA, Karlsson L. 1997. Decreased endosomal delivery of major histocompatibility complex class II-invariant chain complexes in dynamin-deficient cells. J. Biol. Chem. 272: 17055-60
76. Pond L, Watts C. 1999. Functional early endosomes are required for maturation of major histocompatibility complex class II molecules in human B lymphoblastoid cells. J. Biol. Chem. 274:18049-54
77. Claesson-Welsh L, Peterson PA. 1985. Implications of the invariant gamma-chain on the intracellular transport of class II histocompatibility antigens. J. Immunol. 135:3551-57
78. Bikoff EK, Huang LY, Episkopou V, van Meerwijk J, Germain RN, Robertson EJ. 1993. Defective major histocompatibility complex class II assembly, transport, peptide acquisition, and CD4+ T cell selection in mice lacking invariant chain expression. J. Exp. Med. 177:1699-1712
79. Viville S, Neefjes J, Lotteau V, Dierich A, Lemeur M, Ploegh H, Benoist C, Mathis D. 1993. Mice lacking the MHC class II-associated invariant chain. Cell 72:635-48
80. Pinet V, Malnati MS, Long EO. 1994. Two processing pathways for the MHC class II-restricted presentation of exogenous influenza virus antigen. J. Immunol. 152:4852-60
81. Pinet V, Vergelli M, Martin R, Bakke O, Long EO. 1995. Antigen presentation mediated by recycling of surface HLA-DR molecules. Nature 375:603-6
82. Zhong G, Romagnoli P, Germain RN. 1997. Related leucine-based cytoplasmic targeting signals in invariant chain and major histocompatibility complex class II molecules control endocytic presentation of distinct determinants in a single protein. J. Exp. Med. 185:429-38
83. Davidson HW, Reid PA, Lanzavecchia A, Watts C. 1991. Processed antigen binds to newly synthesized MHC class II molecules in antigen-specific B lymphocytes. Cell 67:105-16
84. Pieters J, Horstmann H, Bakke O, Griffiths G, Lipp J. 1991. Intracellular transport and localization of major histocompatibility complex class II molecules and associated invariant chain. J. Cell Biol. 115:1213-23
85. Amigorena S, Drake JR, Webster P, Mellman I. 1994. Transient accumulation of new class II MHC molecules in a novel endocytic compartment in B lymphocytes. Nature 369:113-20
86. Barnes KA, Mitchell RN. 1995. Detection of functional class II-associated antigen: role of a low density endosomal compartment in antigen processing. J. Exp. Med. 181:1715-27
87. Tulp A, Verwoerd D, Dobberstein B, Ploegh HL, Pieters J. 1994. Isolation and characterization of the intracellular MHC class II compartment. Nature 369:120-26
88. Qiu Y, Xu XX, Wandinger-Ness A, Dalke DP, Pierce SK. 1994. Separation of subcellular compartments containing distinct functional forms of MHC class II. J. Cell Biol. 125:595-605
89. West MA, Lucocq JM, Watts C. 1994. Antigen processing and class II MHC peptide-loading compartments in human B-lymphoblastoid cells. Nature 369: 147-51
90. Pierre P, Turley SJ, Gatti E, Hull M, Meltzer J, Mirza A, Inaba K, Steinman RM, Mellman I. 1997. Developmental regulation of MHC class II transport in mouse dendritic cells. Nature 388:787-92
91. Brachet V, Raposo G, Amigorena S, Mellman I. 1997. Ii chain controls the transport of major histocompatibility complex class II molecules to and from lysosomes. J. Cell Biol. 137:51-65
92. Denzin LK, Robbins NF, Carboy-Newcomb C, Cresswell P. 1994. Assembly and intracellular transport of HLA-DM and correction of the class II antigen processing defect in T2 cells. Immunity 1:595-606
93. Lindstedt R, Liljedahl M, Peleraux A, Peterson PA, Karlsson L. 1995. The MHC class II molecule H2-M is targeted to an endosomal compartment by a tyrosine-based targeting motif. Immunity 3:561-72
94. Marks MS, Roche PA, van Donselaar E, Woodruff L, Peters PJ, Bonifacino JS. 1995. A lysosomal targeting signal in the cytoplasmic tail of the beta chain directs HLA-DM to MHC class II compartments. J. Cell Biol. 131:351-69
95. Kovats S, Grubin CE, Eastman S, deRoos P, Dongre A, Van Kaer L, Rudensky AY. 1998. Invariant chain-independent function of H-2M in the formation of endogenous peptide-major histocompatibility complex class II complexes in vivo. J. Exp. Med. 187:245-51
96. Sanderson F, Kleijmeer MJ, Kelly A, Verwoerd D, Tulp A, Neefjes JJ, Geuze HJ, Trowsdale J. 1994. Accumulation of HLA-DM, a regulator of antigen presentation, in MHC class II compartments. Science 266:1566-69
97. Nijman HW, Kleijmeer MJ, Ossevoort MA, Oorschot VM, Vierboom MP, van de Keur M, Kenemans P, Kast WM, Geuze HJ, Melief CJ. 1995. Antigen capture and major histocompatibility class II compartments of freshly isolated and cultured human blood dendritic cells. J. Exp. Med. 182:163-74
98. Pierre P, Denzin LK, Hammond C, Drake JR, Amigorena S, Cresswell P, Mellman I. 1996. HLA-DM is localized to conventional and unconventional MHC class II-containing endocytic compartments. Immunity 4:229-39
99. Kim K-J, Jung H-H, Bae Y-S. 1996. Blood dendritic cells express detectable amounts of class II-related DM protein on the cell surfaces. Mol. Cells 6:684-91
100. Copier J, Kleijmeer MJ, Ponnambalam S, Oorschot V, Potter P, Trowsdale J, Kelly A. 1996. Targeting signal and subcellular compartments involved in the intracellular trafficking of HLA-DMB. J. Immunol. 157:1017-27
101. Copier J, Potter P, Sacks SH, Kelly AP. 1998. Multiple signals regulate the intracellular trafficking of HLA-DM in B-lymphoblastoid cells. Immunology 93: 505-10
102. Liu SH, Marks MS, Brodsky FM. 1998. A dominant-negative clathrin mutant differentially affects trafficking of molecules with distinct sorting motifs in the class II major histocompatibility complex (MHC) pathway. J. Cell Biol. 140:1023-37
103. Ferrari G, Knight AM, Watts C, Pieters J. 1997. Distinct intracellular compartments involved in invariant chain degradation and antigenic peptide loading of major histocompatibility complex (MHC) class II molecules. J. Cell Biol. 139:1433-46
104. Kleijmeer MJ, Raposo G, Geuze HJ. 1996. Characterization of MHC class JJ compartments by immunoelectron microscopy. Methods Companion Methods Enzymol. 10:191-207
105. Robbins NF, Hammond C, Denzin LK, Pan M, Cresswell P. 1996. Trafficking of major histocompatibility complex class II molecules through intracellular compartments containing HLA-DM. Hum. Immunol. 45:13-23
106. Schafer PH, Green JM, Malapati S, Gu L, Pierce SK. 1996. HLA-DM is present in one-fifth the amount of HLA-DR in the class II peptide-loading compartment where it associates with leupeptin-induced peptide (LIP)-HLA-DR complexes. J. Immunol. 157:5487-95
107. Raposo G, Nijman HW, Stoorvogel W, Liejendekker R, Harding CV, Melief CJ, Geuze HJ. 1996. B lymphocytes secrete antigen-presenting vesicles. J. Exp. Med. 183:1161-72
108. Zitvogel L, Regnault A, Lozier A, Wolfers J, Flament C, Tenza D, Ricciardi-Castagnoli P, Raposo G, Amigorena S. 1998. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat. Med. 4:594-600
109. Escola JM, Kleijmeer MJ, Stoorvogel W, Griffith JM, Yoshie O, Geuze HJ. 1998. Selective enrichment of tetraspan proteins on the internal vesicles of multivesicular endosomes and on exosomes secreted by human B-lymphocytes. J. Biol. Chem. 273(32):121-27
110. Hammond C, Denzin LK, Pan M, Griffith JM, Geuze HJ, Cresswell P. 1998. The tetraspan protein CD82 is a resident of MHC class II compartments where it associates with HLA-DR, -DM, and -DO molecules. J. Immunol. 161:3282-91
111. van Ham SM, Tjin EPM, Lillemeier BF, Gruneberg U, van Meijgaarden KE, Pastoors L, Verwoerd D, Tulp A, Canas B, Rahman D, Ottenhoff TH, Pappin DJ, Trowsdale J, Neefjes J. 1997. HLA-DO is a negative modulator of HLA-DM-mediated MHC class II peptide loading. Curr. Biol. 7:950-57
112. Kropshofer H, Vogt AB, Thery C, Armandola EA, Li BC, Moldenhauer G, Amigorena S, Hammerling GJ. 1998. A role for HLA-DO as a co-chaperone of HLA-DM in peptide loading of MHC class II molecules. EMBO J. 17:2971-81
113. Samaan A, Thibodeau J, Mahana W, Castellino F, Cazenave PA, Kindt TJ. 1999. Cellular distribution of a mixed MHC class II heterodimer between DRa and a chimeric DOb chain. Int. Immunol. 11:99-111
114. Mellins E, Smith L, Arp B, Cotner T, Celis E, Pious D. 1990. Defective processing and presentation of exogenous antigens in mutants with normal HLA class II genes. Nature 343:71-74
115. Pious D, Dixon L, Levine F, Cotner T, Johnson R. 1985. HLA class II regulation and structure. Analysis with HLA-DR3 and HLA-DP point mutants. J. Exp. Med. 162:1193-1207
116. Riberdy JM, Newcomb JR, Surman MJ, Barbosa JA, Cresswell P. 1992. HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides. Nature 360:474-77
117. Sette A, Ceman S, Kubo RT, Sakaguchi K, Appella E, Hunt DF, Davis TA, Michel H, Shabanowitz J, Rudersdorf R, et al. 1992. Invariant chain peptides in most HLA-DR molecules of an antigen-processing mutant. Science 258:1801-4
118. Avva RR, Cresswell P. 1994. In vivo and in vitro formation and dissociation of HLA-DR complexes with invariant chain-derived peptides. Immunity 1:763-74
119. Mellins E, Kempin S, Smith L, Monji T, Pious D. 1991. A gene required for class II-restricted antigen presentation maps to the major histocompatibility complex. J. Exp. Med. 174:1607-15
120. Riberdy JM, Cresswell P. 1992. The antigen-processing mutant T2 suggests a role for MHC-linked genes in class II antigen presentation. J. Jmmunol. 148:2586-90
121. Fling SP, Arp B, Pious D. 1994. HLA-DMA and -DMB genes are both required for MHC class II/peptide complex formation in antigen-presenting cells. Nature 368:554-58
122. Denzin LK, Cresswell P. 1995. HLA-DM induces CLIP dissociation from MHC class II αβ dimers and facilitates peptide loading. Cell 82:155-65
123. Kropshofer H, Arndt SO, Moldenhauer G, Haammerling G, Vogt AB. 1997. HLA-DM acts as a molecular chaperone and rescues empty HLA-DR molecules at lysosomal pH. Immunity 6:293-302
124. Mosyak L, Zaller DM, Wiley DC. 1998. The structure of HLA-DM, the peptide exchange catalyst that loads antigen onto class II MHC molecules during antigen presentation. Immunity 9:377-83
125. Fremont DH, Crawford F, Marrack P, Hendrickson WA, Kappler J. 1998. Crystal structure of mouse H2-M. Immunity 9:385-93
126. Sloan VS, Cameron P, Porter G, Gammon M, Amaya M, Mellins E, Zaller DM. 1995. Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature 375:802-6
127. Sherman MA, Weber DA, Jensen PE. 1995. DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide. Immunity 3:197-205
128. van Ham SM, Gruneberg U, Malcherek G, Broker I, Melms A, Trowsdale J. 1996. Human histocompatibility leukocyte antigen (HLA)-DM edits peptides presented by HLA-DR according to their ligand binding motifs. J. Exp. Med. 184:2019-24
129. Denzin LK, Hammond C, Cresswell P. 1996. HLA-DM interactions with intermediates in HLA-DR maturation and a role for HLA-DM in stabilizing empty HLA-DR molecules. J. Exp. Med. 184:2153-65
130. Stern LJ, Wiley DC. 1992. The human class II MHC protein HLA-DR1 assembles as empty alpha beta heterodimers in the absence of antigenic peptide. Cell 68:465-77
131. Germain RN, Rinker A Jr. 1993. Peptide binding inhibits protein aggregation of invariant-chain free class II dimers and promotes surface expression of occupied molecules. Nature 363: 725-28
132. Sadegh-Nasseri S, Stern LJ, Wiley DC, Germain RN. 1994. MHC class II function preserved by low-affinity peptide interactions preceding stable binding. Nature 370:647-50
133. Weber DA, Evavold BD, Jensen PE. 1996. Enhanced dissociation of HLA-DR-bound peptides in the presence of HLA-DM. Science 274:618-20
134. Kropshofer H, Hammerling GJ, Vogt AB. 1997. How HLA-DM edits the MHC class II peptide repertoire: survival of the fittest? Immunol. Today 18:77-82
135. Vogt AB, Kropshofer H, Moldenhauer G, Haemmerling GJ. 1996. Kinetic analysis of peptide loading onto HLA-DR molecules mediated by HLA-DM. Proc. Natl. Acad. Sci. USA 93:9724-29
136. Ramachandra L, Kovats S, Eastman S, Rudensky AY. 1996. Variation in HLA-DM expression influences conversion of MHC class II alpha beta:class II-associated invariant chain peptide complexes to mature peptide-bound class II alpha beta dimers in a normal B cell line. J. Immunol. 156:2196-204
137. Mellins E, Cameron P, Amaya M, Goodman S, Pious D, Smith L, Arp B. 1994. A mutant human histocompatibility leukocyte antigen DR molecule associated with invariant chain peptides. J. Exp. Med. 179:541-49
138. Sanderson F, Thomas C, Neefjes J, Trowsdale J. 1996. Association between HLA-DM and HLA-DR in vivo. Immunity 4:87-96
139. Stern LJ, Brown JH, Jardetzky TS, Gorga JC, Urban RG, Strominger JL, Wiley DC. 1994. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368:215-21
140. Dessen A, Lawrence CM, Cupo S, Zaller DM, Wiley DC. 1997. X-ray crystal structure of HLA-DR4 (DRA*0101, DRB1*0401) complexed with a peptide from human collagen II. Immunity 7:473-81
141. Runnels HA, Moore JC, Jensen PE. 1996. A structural transition in class II major histocompatibility complex proteins at mildly acidic pH. J. Exp. Med. 183:127-36
142. Boniface JJ, Lyons DS, Wettstein DA, Allbritton NL, Davis MM. 1996. Evidence for a conformational change in a class II major histocompatibility complex molecule occurring in the same pH range where antigen binding is enhanced. J. Exp. Med. 183:119-26
143. Ullrich HJ, Doring K, Gruneberg U, Jahnig F, Trowsdale J, van Ham SM. 1997. Interaction between HLA-DM and HLA-DR involves regions that undergo conformational changes at lysosomal pH. Proc. Natl. Acad. Sci. USA 94:13163-68
144. Busch R, Reich Z, Zaller DM, Sloan V, Mellins ED. 1998. Secondary structure composition and pH-dependent conformational changes of soluble recombinant HLA-DM. J. Biol. Chem. 273:27557-64
145. Weber DA, Evavold BD, Jensen PE. 1996. Enhanced dissociation of HLA-DR-bound peptides in the presence of HLA-DM. Science 274:618-20
146. Raddrizzani L, Bono E, Vogt AB, Kropshofer H, Gallazzi F, Sturniolo T, Haemmerling GJ, Sinigaglia F, Hammer J. 1999. Identification of destabilizing residues in HLA class II-selected bacteriophage display libraries edited by HLA-DM. Eur. J. Immunol. 29:660-68
147. Brooks AG, Campbell PL, Reynolds P, Gautam AM, McCluskey J. 1994. Antigen presentation and assembly by mouse I-Ak class II molecules in human APC containing deleted or mutated HLA DM genes. J. Immunol. 153:5382-92
148. Stebbins CC, Loss G Jr, Elias CG, Chervonsky A, Sant AJ. 1995. The requirement for DM in class II-restricted antigen presentation and SDS-stable dimer formation is allele and species dependent. J. Exp. Med. 181:223-34
149. Fung-Leung W-P, Surh CD, Liljedahl M, Pang J, Leturcq D, Peterson PA, Webb SR, Karlsson L. 1996. Antigen presentation and T cell development in H2-M deficient mice. Science 271:1278-81
150. Martin WD, Hicks GG, Mendiratta SK, Leva HI, Ruley HE, Van Kaer L. 1996. H2-M mutant mice are defective in the peptide loading of class II molecules, antigen presentation, and T cell repertoire selection. Cell 84:543-50
151. Miyazaki T, Wolf P, Tourne S, Waltzinger C, Dierich A, Barois N, Ploegh H, Benoist C, Mathis D. 1996. Mice lacking H2-M complexes, enigmatic elements of the MHC class II peptide-loading pathway. Cell 84:531-41
152. Kovats S, Whiteley PE, Concannon P, Rudensky AY, Blum JS. 1997. Presentation of abundant endogenous class II DR-restricted antigens by DM-negative B cell lines. Eur. J. Immunol. 27:1014-21
153. Ma C, Blum JS. 1997. Receptor-mediated endocytosis of antigens overcomes the requirement for HLA-DM in class II-restricted antigen presentation. J. Immunol. 158:1-4
154. Grubin CE, Kovals S, deRoos P, Rudensky AY. 1997. Deficient positive selection of CD4 T cells in mice displaying altered repertoires of MHC class II-bound self-peptides. Immunity 7:197-208
155. Tourne S, Miyazaki T, Oxenius A, Klein L, Fehr T, Kyewski B, Benoist C, Mathis D. 1997. Selection of a broad repertoire of CD4+ T cells in H-2Ma0/0 mice. Immunity 7:187-95
156. Wolf PR, Tourne S, Miyazaki T, Benoist C, Mathis D, Ploegh HL. 1998. The phenotype of H-2M-deficient mice is dependent on the MHC class II molecules expressed. Eur. J. Immunol. 28:2605-18
157. Katz JF, Stebbins C, Appella E, Sant AJ. 1996. Invariant chain and DM edit self-peptide presentation by major histocompatibility complex (MHC) class II molecules. J. Exp. Med. 184:1747-53
158. Weenink S, Averdunk H, Boston T, Boswarva V, Guery JC, Adorini L, Mellins E, McCluskey J, Gautam AM. 1997. Impaired antigen presentation by murine I-Ad class II MHC molecules expressed in normal and HLA-DM-defective human B cell lines. Int. Immunol. 9:889-96
159. Rammensee HG, Friede T, Stevanoviic S. 1995. MHC ligands and peptide motifs: first listing. Immunogenetics 41:178-228
160. Urban RG, Chicz RM, Strominger JL. 1994. Selective release of some invariant chain-derived peptides from HLA-DR1 molecules at endosomal pH. J. Exp. Med. 180:751-55
161. Kropshofer H, Vogt AB, Stern LJ, Hammerling GJ. 1995. Self-release of CLIP in peptide loading of HLA-DR molecules. Science 270:1357-59
162. Tourne S, Miyazaki T, Wolf P, Ploegh H, Benoist C, Mathis D. 1997. Functionality of major histocompatibility complex class II molecules in mice doubly deficient for invariant chain and H-2M complexes. Proc. Natl. Acad. Sci. USA 94:9255-60
163. Kenty G, Martin WD, Van Kaer L, Bikoff EK. 1998. MHC class II expression in double mutant mice lacking invariant chain and DM functions. J. Immunol. 160:606-14
164. Swier K, Brown DR, Bird JJ, Martin WD, Van Kaer L, Reiner SL. 1998. A critical, invariant chain-independent role for H2-M in antigen presentation. J. Immunol. 160:540-44
165. Surh CD, Lee D-S, Fung-Leung W-P, Karlsson L, Sprent J. 1997. Thymic selection by a single MHC/peptide ligand produces a semidiverse repertoire of CD4+ T cells. Immunity 7:209-19
166. Sant' Angelo DB, Waterbury PG, Cohen BE, Martin WD, Van Kaer L, Hayday AC, Janeway CA Jr. 1997. The imprint of intrathymic self-peptides on the mature T cell receptor repertoire. Immunity 7:517-24
167. Lee DS, Ahn C, Ernst B, Sprent J, Surh CD. 1999. Thymic selection by a single MHC/peptide ligand: autoreactive T cells are low-affinity cells. Immunity 10:83-92
168. Barton GM, Rudensky AY. 1999. Requirement for diverse, low-abundance peptides in positive selection of T cells. Science 283:67-70
169. Shachar I, Flavell RA. 1996. Requirement for invariant chain in B cell maturation and function. Science 274:106-8
170. Rolink AG, Brocker T, Bluethmann H, Kosco-Vilbois MH, Andersson J, Melchers F. 1999. Mutations affecting either generation or survival of cells influence the pool size of mature B cells. Immunity 10:619-28
171. Nakagawa TY, Brissette WH, Lira PD, Griffiths RJ, Petrushova N, Stock J, McNeish JD, Eastman SE, Howard ED, Clarke SRM, Rosloniec EF, Elliott EA, Rudensky AY. 1999. Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice. Immunity 10:207-17
172. Gapin L, Bravo de Alba Y, Casrouge A, Cabaniols JP, Kourilsky P, Kanellopoulos J. 1998. Antigen presentation by dendritic cells focuses T cell responses against immunodominant peptides: studies in the hen egg-white lysozyme (HEL) model. J. Immunol. 160:1555-64
173. Chapman HA. 1998. Endosomal proteolysis and MHC class II function. Curr. Opin. Immunol. 10:93-102
174. Kirschke H, Wiederanders B. 1994. Cathepsin S and related lysosomal endopeptidases. Methods Enzymol. 244:500-11
175. Rock KL, Benacerraf B, Abbas AK. 1984. Antigen presentation by hapten-specific B lymphocytes. I. Role of surface immunoglobulin receptors. J. Exp. Med. 160:1102-13
176. Lanzavecchia A. 1985. Antigen-specific interaction between T and B cells. Nature 314:537-39
177. Accolla RS, Cina R, Montesoro E, Celada F. 1981. Antibody-mediated activation of genetically defective Escherichia coli beta-galactosidases by monoclonal antibodies produced by somatic cell hybrids. Proc. Natl. Acad. Sci. USA 78:2478-82
178. Jemmerson R, Paterson Y. 1986. Mapping epitopes on a protein antigen by the proteolysis of antigen-antibody complexes. Science 232:1001-4
179. Simitsek PD, Campbell DG, Lanzavecchia A, Fairweather N, Watts C. 1995. Modulation of antigen processing by bound antibodies can boost or suppress class II major histocompatibility complex presentation of different T cell determinants. J. Exp. Med. 1815:1957-63